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Abstract: Lung diseases represent one of the main causes of death in the world. Making an opportune diagnosis would
improve the quality of life of patients. A set of factors intervene in the diagnostic process that significantly impact the
evolution of the disease. However, there is uncertainty to determine which factors promote the development of lung disease.
The present research aims to propose a method for prioritizing risk factors for chronic obstructive pulmonary disease. The
method uses a multi-criteria approach where uncertainty is modeled using neutrosophic numbers. The proposed method is
implemented in a case study at Alfredo Noboa Montenegro Hospital. The result is the prioritization of the factors whose
mitigation would favor the reduction of lung disease.

Keywords: Pulmonary diseases; diagnosis; neutrosophic numbers.
1. Introduction
Chronic obstructive pulmonary disease is an inflammatory pathology that constitutes a major public health
problem and one of the main causes of mortality [1, 2] in Ecuador and in the world. In recent years, this
phenomenon has shown a constant growth. It has become the fourth cause of death worldwide [3].
Chronic obstructive pulmonary disease is a preventable and treatable condition that creates persistent airflow
limitation that is generally progressive and associated with an enhanced chronic inflammatory response to
noxious particles or gases in the airways and lung [4, 5]. This disease is one of the leading causes of morbidity
and mortality worldwide and generates an economic and social burden that is both substantial and growing [6,
7].
Inhalation of harmful particles, such as tobacco smoke and biomass fuels, cause inflammation that may
become a chronic condition and induce the destruction of parenchymal tissue and alter the normal repair and
defense mechanisms. These pathological changes cause structural modifications and narrowing of the small
airways [8, 9]. Destruction of the lung parenchyma by inflammatory processes leads to the loss of the alveolar
attachments to the small airways and decreases the elastic recoil of the lung; so, these changes decrease the
ability of the airways to remain open during expiration [10, 11].
The alarming prevalence figures for obstructive pulmonary disease [12-14], have motivated this
investigation. The main objective is to develop a method for the prioritization of risk factors for chronic
obstructive pulmonary disease. The method uses a multi-criteria approach where the uncertainty is modeled
using neutrosophic numbers.
The investigation is structured in several sections, so that each one contributes to reach the previously
defined objective. The Preliminaries section describes the main characteristics of chronic obstructive pulmonary
disease and identifies the risk factors associated with this condition. The Materials section proposes the method
for prioritizing risk factors for chronic obstructive pulmonary disease and describe each of the activities in
which it is structured. In the Results section, the proposed method is implemented in a case study at Alfredo
Noboa Montenegro Hospital, where the important results obtained demonstrate the need for an early diagnosis
of the disease and the applicability of the method.
To carry out the research, we decided to make a cross-sectional study. With this research design we
determined the total of cases reported with a diagnosis of chronic obstructive pulmonary disease in the sample
obtained from patients of the internal medicine unit at Alfredo Noboa Montenegro hospital, and the prevalence
L. Wong Vázquez1, M. Fernanda Cueva Moncayo, L. Paola Advendaño Castro. Risk Factors Prioritization for Chronic Obstructive Pulmonary
Disease

50

Neutrosophic Sets and Systems, {Special Issue: Impact of Neutrosophy in solving the Latin American's social problems}, Vol. 37, 2020

of this pathology under study. The review of the medical records made it possible to identify the clinical factors
that influenced the development of this pathology and to analyze the role of the risk factors that most affect
chronic obstructive pulmonary disease and whose prioritization is the object of study in this research.
2. Preliminaries
This section provides a description of the main elements associated with the problem. A study of lung
diseases is carried out as the basis of this investigation. Subsequently, the main risk factors that affect chronic
obstructive pulmonary disease are identified for prioritizing risk factors.
2.1. Pulmonary diseases
Chronic obstructive pulmonary disease is not a single disease, but a general concept that designates various
chronic lung ailments that limit the flow of air in the lungs. Therefore, it is classified as Chronic Bronchitis and
Emphysema [15].
Chronic bronchitis is inflammation of the main airways in the lungs that continues for a long time or that
comes back repeatedly. The main cause is smoking. Secondhand smoke may also cause chronic bronchitis,
which is worsened by environmental pollution, infection, and allergies [16]. It is considered to be chronic when
symptoms persist for more than 90 days a year for two consecutive years, as long as it is not due to a localized
bronchopulmonary disease. Smoking is the most common cause of chronic bronchitis and there is no
precondition for gender, age or ethnicity. Up to 5% of the population can be affected, and it tends to occur more
in women and people over 45 years of age [17, 18].
Pulmonary emphysema is a disease that produces the enlargement of the pulmonary alveoli permanently,
damaging them in such a way that they become obstructed and decrease respiratory function [19, 20]. The loss
of elasticity causes the airways to narrow, as a consequence your body does not receive the oxygen it needs.
This pathology usually appears as a sequel to bronchitis and asthma. Smoking is the most common cause for its
appearance. Emphysema is mainly a disease of people over 40 years of age and is more frequent in men than in
women, although the increase in the incidence of women has been notable in recent years.
The chronic inflammatory process, ischemia, and limitation of physical activity are associated with this
disease, along with the adverse effects of the drugs used in its treatment, produce systemic effects such as
cachexia or muscle atrophy. Concomitant diseases such as hypertension or diabetes mellitus influences the
clinical status of patients with chronic obstructive pulmonary disease and worsens the prognosis, increasing the
risk of developing lung cancer [21, 22]. The prevalence and impact of this disease on the population is expected
to increase due to aging and the rise of the smoking rates of the population, both in developed and
underdeveloped countries. The worldwide prevalence in the general population is estimated at around 1% and
in those over 40 years at 10%.
2.2. Risk factors for chronic obstructive pulmonary disease
Identifying the risk factors that significantly affect lung diseases is the basis for improving the quality of
life of patients. Pulmonary diseases have a multifactorial origin and develop due to the interaction of different
risk factors, such as: genetic factors, bronchial reactivity and environment [23].
Each risk factor has a set of associated measurement indicators that determine the incidence criteria for
medical diagnosis. The risk factors for chronic obstructive pulmonary disease identified from the implemented
research design are listed below:
1. Smoking: considered the most important risk factor for the development of chronic obstructive
pulmonary disease. The risk increases depending on the number of cigarettes smoked, the age
of start, and the time they have been smoking, with tobacco smoke being the main cause [24].
2. Genetic factors: the deficiency of alpha-1-antitrypsin stands out, which is a protein that protects
the lungs from damage. That is why its deficit is associated with the early and accelerated
development of emphysema and decrease in lung function.
It should be analyzed primarily in young patients with chronic obstructive pulmonary disease;
especially if they are not smokers [25].
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3. Bronchial reactivity: this factor is associated with the risk of developing chronic obstructive
pulmonary disease, since people affected by bronchial reactivity usually present bronchial
obstruction [26].
4. Lung growth: people with incomplete lung development have reduced lung function, and
consequently a higher risk of developing chronic obstructive pulmonary disease. Lung growth
disturbances are often associated with events during pregnancy [18, 19].
5. Passive smoking: passive and continuous exposure to tobacco smoke may cause respiratory
symptoms, increase in acute respiratory diseases and worsening lung function, which in the
future may trigger the development of chronic obstructive pulmonary disease [12, 13, 27, 28].
6. Respiratory infections: severe respiratory infections have been associated with decreased lung
function. These infections generally occur in childhood and may cause damage to the airways;
and in adult life cause the appearance of chronic obstructive pulmonary disease.
7. Nutrition: malnutrition is an unfavorable factor in the evolution of this disease. Lack of vitamin
C and E and magnesium decrease protection against the development of chronic obstructive
pulmonary disease.
8. Atmospheric pollution: it contributes to the load of inhaled particles, which produces a greater
number of exacerbations, causing an irritating effect in the airways, which conditions greater
bronchoconstriction and pulmonary hypersecretion.
9. Exposure to toxins: it manifests itself mainly during the combustion of garbage, exposure to
chemicals, combustion at home (wood stove).
10. Demographic factors: the review of medical records showed that demographic elements (Urban,
Rural) influence the development of chronic obstructive pulmonary disease; because patients
in rural areas have a higher exposure to biomass and work mostly in agriculture, which exposes
them to inhalation of chemicals and insecticides.
11. Socioeconomic level: The risk of developing chronic obstructive pulmonary disease is inversely
related to socioeconomic position, in such a way that it is more frequent in depressed social
classes, due to the fact that they present a greater number of risk factors that are associated with
the development of the illness such as: alcohol, smoking, more frequent childhood infections,
overcrowding, poor nutrition.
12. Pathological background: various studies have confirmed that the development of chronic
obstructive pulmonary disease may be associated with pathological elements such as arterial
hypertension, diabetes mellitus, hypothyroidism, hyperthyroidism, among others.
13. Others (age, family history of chronic obstructive pulmonary disease): aging produces an
increase in respiratory symptoms and therefore a decrease in lung function, which leads to a
future development of the pathology. In the family history are genetic factors and most likely
passive smoking that is suffered by the children of the patient with chronic obstructive
pulmonary disease, the same ones who may have a predisposition to smoke in the future.
The identification of risk factors for chronic obstructive pulmonary disease shows that there is no single
cause that provoke this pathology, it is rather the consequence of various risk factors. The problem lies in the
fact that the clinical manifestations of this pathology such as dyspnea, chronic cough, production of profuse and
sometimes purulent expectoration, are of a progressive nature, becoming persistent or evident with effort.
Chronic obstructive pulmonary disease is a slowly progressive disease that, with proper treatment and
compliance with it, the patient can lead a life without complications.
2.3. Neutrosophic multicriteria decision analysis.
Multi-criteria decision-making problems allow uncertainty to be modeled through fuzzy logic, initially
introduced by Zadeh [29]. It allows you to model knowledge in a more natural way. The basic idea is the notion
of the membership relation that takes truth values in the interval [0,1].
The introduction of the Intuitionistic Fuzzy Set (IFS) as a universe with a generalization of fuzzy sets have been
defined by K. Atanassov in [30]. In IFS, in addition to the degree of membership (𝜇𝐴 (𝑥) ∈ [0,1]) of each
element 𝑥 ∈ 𝑋 to a set A, a degree of non-membership 𝑣𝐴 (𝑥) ∈ [0,1], as considered, such as shown in equation
1:
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(1)
∀𝑥 ∈ 𝑋𝜇𝐴 (𝑥 ) + 𝑣𝐴 (𝑥 ) ≤ 1
The Neutrosophic Set (NS) introduced the degree of indeterminacy (i) as an independent component [31].
The truth value in the neutrosophic set is the following [32, 33]:
Let N be a set defined as: 𝑁 = {(𝑇, 𝐼, 𝐹 ): 𝑇, 𝐼, 𝐹 ⊆ [0,1]} a neutrosophic evaluation n is a mapping of the
set of propositional formulas to N, that is, for each p we have:
(2)
𝑣 (𝑝) = (𝑇, 𝐼, 𝐹 )
The Single Valued Neutrosophic Set (SVNS) [34, 35] was developed to facilitate real world applications
of the set theoretic and neutrosophic set operators. An SVNS is a special case of a neutrosophic set proposed as
a generalization of intuitionistic fuzzy sets to treat incomplete information [36-38].
The single value neutrosophic numbers (SVN number) are denoted by
= ( , b, ), where, [0,1] and
𝑎, 𝑏, 𝑐 ∈ [0,1] and 𝑎 + 𝑏 + 𝑐 ≤ 3 [39]. In real world problems, we can sometimes use linguistic terms
like "good", "bad" to get preferences about an alternative, and we cannot use some numbers to express
qualitative information. Some classic multicriteria decision models have been adapted to Neutrosophy, for
example, AHP, TOPSIS and DEMATEL [40-42].
3. Materials and Methods
This section describes the structure and operation of the method to assess risk factors for chronic obstructive
pulmonary disease. The method consists of eight activities: reference framework, collection of parameters,
selection of preferences, calculation of the degree of consensus, control, generation, evaluation of alternatives
and classification of risk factors. It is based in previous works on consensus in neutrosophic environments [4345] . Figure 1 shows the structure of the method.

Method for the evaluation of risk factors for chronic obstructive pulmonary disease

Inputs

Activities

Criteria
Experts

Risk factors

Outputs

1: Framework
2: Collection of parameters
3: Selection of preferences
4: Calculation of the degree of consensus
5: Consensus control
6: Consensus generation
7: Evaluation of alternative
8: Classification of risk factors

Factor
prioritization
prioritization

Figure 1. General diagram of how the method works.

The main activities involved in the proposed method are described below. Each activity describes the main
elements that are managed.
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Activity 1: Framework. This activity defines the evaluation framework for the decision problem of
prioritizing risk factors for chronic obstructive pulmonary disease. The frame is set in such a way that:
𝐶 = {𝑐1 , 𝑐2 , . . 𝑐𝑛 }, 𝑛 ≥ 2, is the set of criteria that represent risk factors for chronic obstructive pulmonary
disease.
𝐸 = {𝑒1 , 𝑒2 , . . 𝑒𝑘 }, 𝑘 ≥ 2, is the set of experts involved in the process.
𝑋 = {𝑥1 , 𝑥2 , . . 𝑥𝑚 }, 𝑚 ≥ 2, is the finite set of patients to be diagnosed.
Criteria and experts could be grouped. The group of experts will provide the evaluations of the decision
problem. The main criteria that represent risk factors for chronic obstructive pulmonary disease according to
[23]. Figure 2 shows the identified factors.
1. Smoking
2. Genetic factors
3. Bronchial Reactivity

Risk factors

4. Lung growth
5. Passive smoking
6. Respiratory infections
7. Nutrition
8. Atmospheric pollution
9. Exposure to toxins
10 Pathological Background
11. Family background
Figure 2. Risk factors for chronic obstructive pulmonary disease.

Activity 2: collection of parameters. The granularity of the linguistic term is selected. Parameters are brought
together to control the consensus process: consensus threshold μ [0,1] and MAXROUND N to limit the
maximum number of discussion rounds. The acceptability threshold 𝜀 ≥ 0, is also collected, to allow a margin
of acceptability to avoid generating unnecessary recommendations.
Activity 3: selection of preferences. For each expert, their preference is compiled using the chosen set of
linguistic terms.
In this activity, each 𝑒𝑘 expert, provides the evaluations using evaluation vectors:
(3)
𝑈 𝑘 = (𝑣1 , 𝑖 = 1, . . 𝑛, 𝑗 = 1, . . 𝑚)
The evaluation, 𝑣𝑖𝑘 provided by each expert 𝑒𝑘 for each criterion 𝑐𝑖 of each alternative 𝑋𝑗 , is expressed by
SVN numbers.
Activity 4: calculation of the degree of consensus. The degree of standardized collective consensus is
calculated in a range of values [0,1].
For each pair of experts, 𝑒𝑘 , 𝑒𝑡 (𝑘 < 𝑡) s a similarity vector is determined
𝑆𝑀𝑘𝑡 = (𝑠𝑚𝑖𝑘𝑡 ), 𝑠𝑚𝑖𝑘𝑡 ∈ [0,1]
(4)
is calculated:
̅
2
(5)
𝑛
1
2
2
2
𝑘𝑡
𝑘
𝑡
𝑘
𝑡
𝑘
𝑡
𝑠𝑚𝑖 = 1 − ( ∑ {(|𝑡𝑖 − 𝑡𝑖 |) + (|𝑖𝑖 − 𝑡𝑖 |) + (|𝑓𝑖 − 𝑡𝑖 |) })
3
𝑗=1

(𝑖, 2, . . , 𝑚)
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A consensus vector 𝐶𝑀 = (𝑐𝑚𝑖 ) is obtained by adding similarity values:
𝑐𝑚𝑖 = 𝑂𝐴𝐺1 (𝑆𝐼𝑀𝑖 )

(6)

(𝑚−1)𝑚

1𝑚
Where 𝑂𝐴𝐺1 is an aggregation operator, 𝑆𝐼𝑀𝑖 = {𝑠𝑚12
𝑖 , 𝑠𝑚𝑖 , . . , 𝑠𝑚𝑖

} representing all pairs of

experts determines the similarity in their opinion on the preference between (𝑣𝑖 , 𝑣𝑗 ) and 𝑐𝑚𝑖 is the degree of
consensus reached by the group in their opinion. Finally, a degree of general consensus is calculated:
∑𝑛𝑖=1 𝑐𝑣𝑖
(7)
𝑐𝑔 =
𝑛
Activity 5: consensus control. The degree of consensus cg is compared with the consensus threshold (μ). If
𝑐𝑔 ≥ 𝜇, the consensus process ends; otherwise, the process requires additional discussion. The number of
rounds is compared to the MAXROUND parameter to limit the maximum number of discussion rounds.
Activity 6: consensus generation. When𝑐𝑔 < 𝜇, the experts must modify the preference relationships to
make their preferences close to each other and increase the degree of consensus in the next round. The consensus
generation begins to compute the collective preferences 𝑤 𝑐 . This collective preference model is calculated by
adding the reference vector of each expert:
(8)
𝑤 𝑐 = 𝑂𝐴𝐺2 (𝑣1 , . . 𝑣 𝑚 )
Where: 𝑂𝐴𝐺2 is an aggregation operator and 𝑣 ∈ 𝑈. After that, a proximity vector (𝑃𝑃𝑘 ) is obtained
𝑘
between each of the expert 𝑒𝑘 and 𝑤 𝑐 . The proximity values, 𝑝𝑝𝑖𝑗
∈ [0,1] are calculated as:
̅
2
(9)
𝑛
1
𝑘
𝑘
𝑐 2
𝑘
𝑐 2
𝑘
𝑐 2
𝑝𝑝𝑖𝑗 = ( ∑ {(|𝑡𝑖 − 𝑡𝑖 |) + (|𝑖𝑖 − 𝑡𝑖 |) + (|𝑓𝑖 − 𝑡𝑖 |) })
3
𝑗=1

Subsequently, preference relationships to change (CC) are identified. The preference relationship between
the criteria 𝑐𝑖 and 𝑐𝑗 with a degree of consensus, below the defined (μ) is identified:
𝐶𝐶 = {𝑤𝑖𝑐 |𝑐𝑚𝑖 | < 𝜇}
(10)
Then, depending on the CC, those experts who should change their preference are identified. To calculate
an average proximity 𝑝𝑝𝑖𝐴 , the proximity measures are added.
𝑝𝑝 𝐴 = 𝑂𝐴𝐺2 (𝑝𝑝1 , . . , 𝑝𝑝𝑖𝑚 )
(11)
Where 𝑂𝐴𝐺2 is an SVN aggregation operator.
𝑒𝑘 experts whose 𝑝𝑝𝑖𝑘 < 𝑝𝑝𝑖𝐴 are advised to modify their preference ratio 𝑊𝑖𝑘 .
Finally, the direction rules are checked to suggest the direction of the proposed changes. A threshold 𝜀 ≥ 0
has been established to avoid generating an excessive number of unnecessary tips.
DR 1: If 𝑣𝑖𝑘 − 𝑤𝑖𝑐 < −𝜀 then 𝑒𝑘 should increase its value of the preference relation 𝑣𝑖 .
DR 2: If 𝑣𝑖𝑘 − 𝑤𝑖𝑐 < −𝜀 then 𝑒𝑘 should decrease its value of the preference relation 𝑣𝑖 .
DR 3: If −𝜀 ≤ 𝑣𝑖𝑘 − 𝑤𝑖𝑐 ≤ −𝜀 then 𝑒𝑘 must not modify the value of the preference relation 𝑣𝑖 .
Steps 3 through 6 are repeated until the consensus reaches the maximum number of rounds.
Activity 7: evaluation of alternatives. The objective of this activity is to obtain a global evaluation for each
alternative. Taking into account the previous phase, an evaluation is calculated for each alternative, using the
selected resolution process that allows managing the information expressed in the decision frame.
In this case, the alternatives are classified according to the single value neutrosophic weighted average
aggregation operator (SVNWA):
𝑛

𝐹𝑤 (𝐴1 , 𝐴2 , . . , 𝐴𝑛 , ) = 〈1 − ∏

𝑗=1

𝑗

𝑛

(1 − 𝑇𝐴𝑗 ) , ∏

𝑗=1

𝑤𝑗

(𝐼𝐴𝑗 (𝑥 ))

𝑛

,∏
𝑗=1

𝑤𝑗

(𝐹𝐴𝑗 (𝑥 )) 〉

(12)

Where 𝑊 = (𝑤1 , 𝑤2 , , . . 𝑤𝑛 ) is the weight vector of 𝐴𝑗 (𝑗 = 1,2, , . . , 𝑛), 𝑤𝑛 ∈ [0,1] and ∑𝑛𝑗 𝑤𝑗 .
Activity 8: classification of risk factors. In this activity, the alternatives are ranked and the best scoring
function is chosen [29]. According to the scoring and precision functions of the SVN sets, a sort order of the set
of alternatives can be generated [46]. Selecting the options with the highest score.
To order alternatives a scoring function is used [35]:
𝑠(𝑉𝑗 ) = 2 + 𝑇𝑖 + 𝐹𝑗 − 𝐼𝑗
(13)
Additionally, a precision function is defined:
𝑎(𝑉𝑗 ) = 𝑇𝑖 − 𝐹𝑗
(14)
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So
1. Si
a. 𝑎(𝑉𝑗 ) = 𝑎(𝑉𝑖 ), then 𝑉𝑗 are equal, denoted by 𝑉𝑗 = 𝑉𝑖 .
b. 𝑎(𝑉𝑗 ) < 𝑎(𝑉𝑖 ), then 𝑉𝑗 is less than 𝑉𝑖 , denoted by 𝑉𝑗 < 𝑉𝑖 .
3. Si 𝑠(𝑉𝑗 ) < 𝑠(𝑉𝑖 ), then 𝑉𝑗 is less than 𝑉𝑖 , denoted by 𝑉𝑗 < 𝑉𝑖.
a.
Si 𝑎 (𝑉𝑗) < 𝑎 (𝑉𝑖), then 𝑉𝑗 is less than 𝑉𝑖 , denoted by 𝑉𝑗 < 𝑉𝑖 .
b.
Si a (𝑉𝑗) = 𝑎 (𝑉𝑖) , then 𝑉𝑗 and 𝑉𝑖 are equal, denoted by 𝑉𝑗 = 𝑉𝑖.
Another option is to use the scoring function proposed in [47]:
𝑠(𝑉𝑗 ) = (1 + 𝑇𝑗 − 2𝐹𝑗 − 𝐼𝑗 )/2

(15)

where 𝑠(𝑉𝑗 ) ∈ [−1,1] .
According to the classification method of the SVN scoring function[48, 49], the classification order of the
set of risk factors for chronic obstructive pulmonary disease can be generated and the alternatives can be
prioritized.
4. Results
To demonstrate the applicability of the proposed method, we decided to conduct a case study, taking as a
reference a patient admitted to the intensive care unit at Alfredo Noboa Montenegro Hospital in Ecuador. In
this study, we had the collaboration of three experts 𝐸 = {𝑒1 , 𝑒2 , 𝑒3 }, 𝑛 = 3 from which their preferences are
determined. To increase the way in which the input data is interpreted, a set of linguistic terms with cardinality
nine is used (Table 1).
Linguistic terms

SVNSs

Extremely good (EG)

(1,0,0)

Very very good (VVG)

(0.9, 0.1, 0.1)

Very good (VG)

(0.8,0,15,0.20)

Good (G)

(0.70,0.25,0.30)

Medium good (MG)

(0.60,0.35,0.40)

Medium (M)

(0.50,0.50,0.50)

Medium bad (MB)

(0.40,0.65,0.60)

Bad (B)

(0.30,0.75,0.70)

Very bad (VB)

(0.20,0.85,0.80)

Very very bad (VVB)

(0.10,0.90,0.90)

Extremely bad (EB)

(0,1,1)

Table 1. Linguistic terms used to provide the assessments [47].

The scope of the consensus process is defined by eleven criteria 𝐶 = {𝑐1 , 𝑐2 , . . , 𝑐11 } shown in Table 2.
Node Description
𝑐

1

Smoking

𝑐

2

Genetic factors

𝑐

3

Bronchial reactivity

𝑐

4

Lung growth

𝑐

5

Passive smoking

𝑐

6

Respiratory infections

𝑐

7

Nutrition
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8

Atmospheric pollution

𝑐

9

𝑐

10

Pathological background

𝑐

11

Family background

Exposure to toxins

Table 2. Criteria for prioritizing risk factors for chronic obstructive pulmonary disease.

The parameters used in this case study are shown in Table 3.
Consensus threshold
𝜇 = 0,9

Maximum number of discussion rounds

MAXROND =10

Acceptability threshold

𝜀 = 0.1

Table 3. Defined parameters.

Initially, experts provide the following preferences:
𝒄𝟏

𝒄𝟐

𝒄𝟑

𝒄𝟒

𝒄𝟓

𝒄𝟔

𝒄𝟕

𝒄𝟖

𝒄𝟗

𝒄𝟏𝟎

𝒄𝟏𝟏

E1

B

M

B

VG

G

G

G

B

G

M

B

E2

VG

G

G

G

G

G

G

VG

G

G

VG

E3

VB

VG

M

G

VG

VG

G

VB

VG

VG

VG

Table 4. Preference Round 1

First round
Similarity vectors are obtained.
𝑠12 =[ 0,9226; 0,9221; 0,95; 0,5807; 0,9702; 0,9707;
0,9707; 0,6807;
0,9204; 0,9606; 0,9606]
𝑠13 =[0,9402; 0,9414; 0,7424; 0,62; 0,9802; 0,9707; 0,7825; 0,8752; 0,9608; 0,9604; 0,9204]
𝑠 23 = [0,9204; 0,9704; 0,9414; 0,7234; 0,9428; 0,9406; 0,9207; 0,896; 0,9554; 0,9402; 0,9606]
The consensus vector obtained is CV = [0,9277; 0,9446; 0,8779; 0,6413; 0,9644; 0,9606; 0,8913
0,8173; 0,9455; 0,9537; 0,9472]. Finally, a degree of general consensus is calculated: cg = 0.8974
Since cg 0.6848 <μ 0.9, the generation of tips is activated.
The collective preferences are calculated using the SVNWA operator, in this case giving the same
importance to each expert W c =[ (0,80; 0,15; 0,20)(0,65; 0,50; 0,50)(0,5; 0,50;0,50)(0,70; 0,25; 0,30)
(0,70; 0,25; 0,30)(0,70; 0,25; 0,30)(0,70; 0,25; 0,30)(0,60;0,40;0,40)(0,70; 0,25; 0,30)(0,6; 0,40;0,40)
(0,60;0,40;0,40)]
The proximity vectors are calculated 𝑘
𝑝𝑝1 =[0,92; 0,92; 0,95; 0,58; 0,97; 0,97; 0,97; 0,68; 0,92; 0,96; 0,96]
𝑝𝑝2 =[0,94; 0,94; 0,94; 0,62; 0,98; 0,97; 0,78; 0,87; 0,96; 0,96; 0,92]
𝑝𝑝3 =[0,92; 0,97; 0,94; 0,72; 0,94; 0,94; 0,92; 0,89; 0,95; 0,94; 0,96]
Then the exchange preferences (CC) are identified.
𝐶𝐶 = {𝑤𝑖𝑐 |𝑐𝑚𝑖 | < 0.9}= 𝑤4 , 𝑤8
The average proximity for this value is calculated as follows:
𝑝𝑝4𝐴 = 0.6413, 𝑝𝑝8𝐴 = 0.8173
The proximity values for each preference expert 𝑤4 , 𝑤8 as follows:
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𝑝𝑝41 = 0.611, 𝑝𝑝81 = 0.979
𝑝𝑝42 = 0.9605, 𝑝𝑝82 = 0.8462
𝑝𝑝43 = 0.9682 𝑝𝑝83 = 0.8566
The preference sets to change are: {𝑣4 , 𝑣8 }
According to the DR1 rule, experts are required to increase the following ratios: 𝑣41
According to the DR2 rule, experts are required to decrease the following relationships: 𝑣82 ,
and according to rule DR3, these relationships should not be changed: 𝑣83
Second round
In accordance with the previous advice, the experts implemented changes and the new preferences obtained
are shown in table 5.
𝒄𝟏
E1

B

𝒄𝟐
M

𝒄𝟑
B

𝒄𝟒
G

𝒄𝟓
G

𝒄𝟔
G

𝒄𝟕
G

𝒄𝟖
B

𝒄𝟗
G

𝒄𝟏𝟎
M

𝒄𝟏𝟏
B

E2

VG

G

G

G

G

G

G

B

G

G

VG

E3

VB

VG

M

G

VG

VG

G

B

VG

VG

VG

Table 5. Round 2 Preferences.

Similarity vectors are again obtained:
𝑠12 =[ 0,9226; 0,9221; 0,95; 0,9207; 0,9702; 0,9707;
0,9707; 0,9207;
0,9204; 0,9606; 0,9606]
𝑠13 =[0,9402; 0,9414; 0,7424; 0,962; 0,9802; 0,9707; 0,7825; 0,9652; 0,9608; 0,9604; 0,9204]
𝑠 23 = [0,9204; 0,9704; 0,9414; 0,9472; 0,9428; 0,9406; 0,9207; 0,9406; 0,9554; 0,9402; 0,9606]
The consensus vector CV = [0,9277; 0,9446; 0,8779; 0,94; 0,9644; 0,9606; 0,8913;
0,94 0,9455;
0,9537; 0,9472; 0,9357]
Finally, a degree of general consensus is calculated: cg=0.9357
Since cg = 0.93>μ = 0.9, the desired level of consensus is reached.
From the result obtained, we concluded that the prioritized risk factors were 𝐶 = 𝑐1 , 𝑐10 , 𝑐8 , 𝑐9 respectively,
which correspond to smoking, family history, air pollution and genetic factors.
Conclusions
The proposed method consists of eight activities, includes automatic search mechanisms for areas of conflict
and recommendations to experts to bring their preferences closer. A study was carried out from which it was
possible to show that the prevalence of chronic obstructive pulmonary disease in the population selected for the
study was high and the prevalent risk factors are smoking, family history, primary education, air pollution and
genetic factors. The implementation of the proposed method allowed the prioritization of risk factors.
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